About this trial
The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Osteoarthritis, and in addition, provide basis for exploring the treatment regimen of UC-MSC therapy in different degree of cartilage defect disease
Eligibility criteria
Qualifiers
Diagnosis of Knee Osteoarthritis by Kellgren and Lawrence Grading Scale, classified with Grade 2-3
Confirm with cartilage injury,articular cartilage part or full-thickness injury, by MR (Magnetic Resonance)
Age <70, no serious organ dysfunction
Over 2 years knee pain or no very effective with conservative treatments
Disqualifiers
Refuse to sign the consent form, or cannot keep follow-up visit
Age >70; Age <70, but with multiple organ failure
Unstable vital signs (breath, blood pressure, pulse)
Combined with knee ligament (anterior and the posterior cruciate ligament, medial and lateral collateral ligament) rupture, laxity, etc.
Trial design
Treatments tested in this trial
- Low dose mesenchymal stem cells
- High dose mesenchymal stem cells
- Intraarticular injection